Dr Agarwal's Eye Hospital Ltd announced a shareholder meeting on July 2, 2026, to approve its amalgamation with Dr Agarwal's Health Care Ltd. The exchange ratio is 23 AHCL shares for every 2 AEHL shares.
Dr Agarwal's Eye Hospital Shareholders to Vote on Amalgamation with AHCL
Dr Agarwal’s Eye Hospital Limited (AEHL) shareholders will vote on a proposed amalgamation with Dr Agarwal’s Health Care Limited (AHCL) on July 2, 2026. Share exchange ratio: 23 AHCL shares for every 2 AEHL shares. ## What just happened The National Company Law Tribunal (NCLT) has directed a meeting of AEHL shareholders to approve the Scheme of Amalgamation with AHCL. The meeting is scheduled for July 02, 2026, at The Music Academy, Chennai. ## Why this matters This is a key step towards consolidating the businesses of AEHL and AHCL. Management expects the merger to enhance operational efficiencies, streamline corporate structures, and lead to Earnings Per Share (EPS) accretion from the first year. ## The backstory For the fiscal year 2025, AHCL reported standalone revenues of ₹1,043.89 crore and Profit After Tax (PAT) of ₹21.93 crore, with EBITDA at ₹298.91 crore. AEHL, on the other hand, reported standalone revenues of ₹397.15 crore and PAT of ₹54.65 crore, with EBITDA at ₹123.59 crore. The amalgamation aims to create a larger, more integrated entity. ## What changes now If approved, AEHL will merge into AHCL. Shareholders of AEHL will receive 23 equity shares of AHCL for every 2 shares they hold, based on a valuation report. The voting process includes both remote e-voting from June 7 to July 1, 2026, and in-person voting at the meeting. ## Risks to watch Shareholders need to consider potential dilution if they hold shares in AHCL and understand the full terms of the scheme, which are available on the company's website. ## Peer comparison * AHCL FY25 Revenue: ₹1,043.89 crore, PAT: ₹21.93 crore, EBITDA: ₹298.91 crore. * AEHL FY25 Revenue: ₹397.15 crore, PAT: ₹54.65 crore, EBITDA: ₹123.59 crore. ## Context metrics (time-bound) * AHCL FY25 Standalone Revenue: ₹1,043.89 crore. * AEHL FY25 Standalone Revenue: ₹397.15 crore. * E-voting period: June 07, 2026 - July 01, 2026. * Meeting Date: July 02, 2026. ## What to track next Investors should monitor the outcome of the shareholder meeting and subsequent NCLT approvals. The market will also watch for post-merger performance and synergy realization.
Get stock alerts instantly on WhatsApp
Quarterly results, bulk deals, concall updates and major announcements delivered in real time.
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.
